How to Manage Nitrosamine Contamination in Active Pharmaceutical Ingredients
In 2018, the detection of nitrosamines in sartan-type drugs, medications to treat high blood pressure and heart failure,...
AMSbiopharma launches an Innovation Plan to strengthen its position in the biopharmaceutical analytical services sector
AMSbiopharma, a CRO (Contract Research Organization) belonging to AMSlab Group and specialized in advanced analytical services for the...
New update for the ICH Q2 (R2) guidance on Analytical Process Validation
As planned for months, the draft ICH Q14 Guideline for AQbD Method Development and the draft ICH Q2...
AMSbiopharma and LEF announce strategic partnership to expand service offering
AMSbiopharma is pleased to announce a new strategic partnership with LEF, a CRO and CDMO based in Portugal...
AMSbiopharma introduces an important advance for the analysis of nitrosamines in different active pharmaceutical ingredients of vitamin B12
AMSbiopharma, our specialized line of analytical solutions for the quality control of pharmaceutical products, announces the launch of...
The R&D&I projects NANOFLUITEDEC and Digital BIOCoV develop a functional prototype for the detection of SARS-Cov-2 virus RNA and an early detection system for anticovid activity from natural products
This morning, the event to present the results of the R&D&I projects NANOFLUIDETEC and DIGITAL BIOCoV, within the...
New facilities with the highest standards of quality, comfort and energy efficiency
In the AMSlab Group, we continue to be immersed in a series of changes that are taking place...
A Galician consortium comprising AMSlab, AMSbiopharma, BFLOW and USC investigates PCR-based SARS-COV-2 detection systems
The project called Rapid and automatable detection for SARS-Cov-2 based on PCR, nanotechnology and microfluidics (NANOFLUIDETEC) is investigating...